These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 490325)

  • 1. CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers.
    Waldmeier PC; Baumann PA; Maítre L
    J Pharmacol Exp Ther; 1979 Oct; 211(1):42-9. PubMed ID: 490325
    [No Abstract]   [Full Text] [Related]  

  • 2. The 5-hydroxytryptamine-releasing properties of two epimer quinoline derivatives.
    Le Fur G; Imbault F; Mitrani N; Marquis F; Renault C; Dubroeucq MC; Gueremy C; Uzan A
    Neuropharmacology; 1984 Feb; 23(2A):169-73. PubMed ID: 6717757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent studies with 4-chloramphetamine and some analogues.
    Fuller RW; Molloy BB
    Adv Biochem Psychopharmacol; 1974; 10():195-205. PubMed ID: 4846538
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 4-(3-indolyl-alkyl)piperidine derivatives on uptake and release of noradrenaline, dopamine and 5-hydroxytryptamine in rat brain synaptosomes, rat heart and human blood platelets.
    Le Fur G; Uzan A
    Biochem Pharmacol; 1977 Mar; 26(6):497-503. PubMed ID: 849346
    [No Abstract]   [Full Text] [Related]  

  • 5. Amine uptake inhibitors: criteria of selectivity.
    Maître L; Moser P; Baumann PA; Waldmeier PC
    Acta Psychiatr Scand Suppl; 1980; 280():97-110. PubMed ID: 6996434
    [No Abstract]   [Full Text] [Related]  

  • 6. Some neuropharmacological effects of Ro 11-2465--a novel tricyclic antidepressant with potent inhibitory activity on the uptake of 5-HT.
    Da Prada M; Keller HH; Burkard WP; Schaffner R; Bonetti EP; Launay JM; Haefely W
    Adv Biochem Psychopharmacol; 1982; 31():235-48. PubMed ID: 6177199
    [No Abstract]   [Full Text] [Related]  

  • 7. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
    Yáñez M; Fraiz N; Cano E; Orallo F
    Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of heavy metals on monoamine uptake and release in brain synaptosomes and blood platelets.
    Komulainen H; Tuomisto J
    Neurobehav Toxicol Teratol; 1982; 4(6):647-9. PubMed ID: 7170022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress.
    Bliss EL; Ailion J; Zwanziger J
    J Pharmacol Exp Ther; 1968 Nov; 164(1):122-34. PubMed ID: 4387046
    [No Abstract]   [Full Text] [Related]  

  • 10. Conformationally rigid amine analogues as tools for studying the molecular requirements of uptake mechanisms.
    Tuomisto J; Tuomisto L
    Med Biol; 1974 Jun; 52(3):176-80. PubMed ID: 4423164
    [No Abstract]   [Full Text] [Related]  

  • 11. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoamines (3): postmortem studies on the human brain in a suicide group].
    Gottfries CG; Winblad B
    Lakartidningen; 1978 Feb; 75(8):663-5. PubMed ID: 634000
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the effects of the selective 5-HT uptake inhibitor WY 27587 on 5-HT uptake into platelets and synaptosomes in the rat.
    Billingsley AJ; Brammer NT; Wood MD; Minchin MC
    Neuropharmacology; 1989 Jan; 28(1):33-6. PubMed ID: 2522598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of progesterone, beta-estradiol, and testosterone on the uptake and metabolism of 3H-norepinephrine, 3H-dopamine and 3H-serotonin in rat brain synaptosomes.
    Nixon RL; Janowsky DS; Davis JM
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):233-6. PubMed ID: 4811456
    [No Abstract]   [Full Text] [Related]  

  • 15. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
    Wong DT; Bymaster FP; Horng JS; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):804-11. PubMed ID: 1151730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA; Martello AL; Katz JL; Martello MB
    J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of hyper- and hypothyroidism on serotonin and noradrenaline concentration and monoamine oxidase activity in the nerve endings of the brains of rats].
    Kononenko VIa; Savits'kiĭ SIu
    Ukr Biokhim Zh; 1974; 46(2):152-6. PubMed ID: 4828104
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: The effect of mepiprazole on the uptake of norepinephrine, dopamine and serotonin into rat brain synaptosomes.
    Placheta P; Singer E; Krivanek W; Hertting G
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R4. PubMed ID: 1143436
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proserotoninergic agents and depression (author's transl)].
    Uzan A
    Encephale; 1982; 8(2):273-89. PubMed ID: 6286277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.